Published in Clin Med Cardiol on April 01, 2009
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet (2000) 8.46
Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med (2004) 3.26
Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation (2003) 2.77
Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med (2004) 1.93
Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol (2002) 1.80
Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes. QJM (2006) 1.53
Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation (2005) 1.40
Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol (2001) 1.26
Current controversies around tight glucose control in critically ill patients. Curr Opin Clin Nutr Metab Care (2007) 1.17
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction. Eur Heart J (2004) 1.13
Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J (2007) 1.12
Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J (2004) 1.10
TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes (1997) 1.06
Insulin: an endogenous cardioprotector. Curr Opin Crit Care (2003) 1.02
Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care (2008) 0.97
Admission glycaemia and outcome after acute coronary syndrome. Int J Cardiol (2006) 0.96
Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarction. Am Heart J (2007) 0.94
Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels. Cardiovasc Res (2002) 0.92
The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med (2005) 0.90
Diabetes and stress hyperglycemia associated with myocardial infarctions at an urban municipal hospital: prevalence and effect on mortality. Cardiol Rev (2005) 0.90
Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur J Cardiovasc Prev Rehabil (2007) 0.89
Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J (1998) 0.88
Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care: a population-based follow-up study in the Skaraborg Project. Scand J Prim Health Care (2007) 0.87
Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J (1988) 0.86
Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era. Diabetes Res Clin Pract (2004) 0.86
Importance of a history of hypertension for the prognosis after acute myocardial infarction--for the Bucindolol Evaluation in Acute myocardial infarction Trial (BEAT) study group. Clin Cardiol (2004) 0.81
Acute myocardial infarction in patients treated for hypertension in the Skaraborg Hypertension Project. Eur Heart J (1993) 0.80
[Hyperglycemia and cardiovascular events]. Dtsch Med Wochenschr (2004) 0.77
QTc Interval and QT Dispersion in Patients with Thalassemia Major: Electrocardiographic (EKG) and Echocardiographic Evaluation. Clin Med Insights Cardiol (2010) 0.92
Association of methylenetetrahydrofolate reductase (C677T) polymorphism with hyperuricemia. Nutr Metab Cardiovasc Dis (2006) 0.84
Profile of mental disorders among the elderly United Arab Emirates population: sociodemographic correlates. Int J Geriatr Psychiatry (2004) 0.81
Evaluation of the teaching strategy of cardiovascular system in a problem-based curriculum: student perception. Adv Physiol Educ (2004) 0.78
The pro-BNP Serum Level and Echocardiographic Tissue Doppler Abnormalities in Patients with Beta Thalassemia Major. Clin Med Insights Cardiol (2010) 0.77
The impact of two different doses of chelating therapy (deferasirox) on echocardiographic tissue Doppler indices in patients with thalassemia major. Eur J Haematol (2011) 0.75